Report shows 241 blood cancer drugs in the pipeline

04/29/2013 | Drug Store News

According to the Pharmaceutical Research and Manufacturers of America, as many as 241 blood cancer medications are undergoing clinical development or FDA assessment, 98 of which are dedicated to lymphoma treatment, while 97 are for leukemia, 52 target multiple myeloma and 24 address bone marrow, blood and lymph node malignancies.

View Full Article in:

Drug Store News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Chief Quality Officer
UnityPoint Clinic
Des Moines, ID
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
The Pew Charitable Trusts
Director, Antibiotics and Innovation Project
Washington, DC
Senior Officer, Drugs and Medical Devices
The Pew Charitable Trusts
Washington, DC